Is PayPal Stock Finally a Buy?
Shares of online payment giant PayPal (NASDAQ:PYPL) have struggled over…
Sell
36
ACTU Quote, Financials, Valuation and Earnings
Last price:
$6.13
Seasonality move
:
7.64%
Day range:
$6.01 - $6.28
52-week range:
$5.47 - $11.99
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
1,977.79x
Volume:
35.3K
Avg. volume:
59.4K
1-year change:
-29.83%
Market cap:
$127.4M
Revenue:
--
EPS (TTM):
-$1.17
Earnings Data
Next earnings date for ACTU
Nov 13
2025
Most recent earnings per share
-$0.30
Beat by $0.01
(Aug 29/2025)
Consensus Estimate
-$0.32
(Aug 29/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
ACTU Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 12/31/2025 | Q4 | -- | -- | -- | -$0.27 | -- |
| 11/13/2025 | Q3 | -- | -- | -- | -$0.28 | -- |
| 08/29/2025 | Q2 | -- | -- | -$0.30 | -$0.32 | $0.01 |
| 05/15/2025 | Q1 | -- | -- | -$0.32 | -$0.30 | -$0.02 |
| 03/14/2025 | Q4 | -- | -- | -$0.33 | -$0.29 | -$0.04 |
| 11/13/2024 | Q3 | -- | -- | -$0.55 | -- | -- |
| 06/30/2024 | Q2 | -- | -- | -- | -- | -- |
| 03/31/2024 | Q1 | -- | -- | -- | -- | -- |
| 12/31/2023 | Q4 | -- | -- | -$0.40 | -- | -- |
| 09/30/2023 | Q3 | -- | -- | -- | -- | -- |
| 06/30/2023 | Q2 | -- | -- | -- | -- | -- |
| 03/31/2023 | Q1 | -- | -- | -- | -- | -- |
Actuate Therapeutics, Inc. Earnings Questions
-
How Much did Actuate Therapeutics, Inc. Generate in Revenue Last Quarter?
Actuate Therapeutics, Inc. reported -- worth of top line sales in its most recent quarter.
-
Did Actuate Therapeutics, Inc. Beat Earnings Last Quarter?
Actuate Therapeutics, Inc. announced earnings per share of -$0.30 which represents a beat of analyst forecast a -$0.32 per share.
-
Is Actuate Therapeutics, Inc. Profitable?
Actuate Therapeutics, Inc. reported -- that represents -- per share over the last quarter.
-
What is the Analyst Consensus for Actuate Therapeutics, Inc. EPS Next Year?
Actuate Therapeutics, Inc.'s earnings are forecast to decrease from -$1.40 per share to -$1.15 per share next year representing a decrease of -17.86%.
-
When is Actuate Therapeutics, Inc.'s Earnings Date?
Actuate Therapeutics, Inc.'s next earnings date is November 13, 2025.
Related Companies
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Did Sprouts Stock Fall So Much?
Shares of health-oriented grocery chain Sprouts Farmers Market (NASDAQ:SFM) have…
Why Did Amazon Go Up So Much?
Shares of Amazon (NASDAQ:AMZN) soared late last week, bringing the…
Stock Ideas
Sell
49
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
61
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 36x
Sell
43
Is MSFT Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 36x
Alerts
Buy
100
GMED alert for Nov 8
Globus Medical, Inc. [GMED] is up 35.94% over the past day.
Buy
73
GCT alert for Nov 8
GigaCloud Technology, Inc. [GCT] is up 30.05% over the past day.
Buy
84
FROG alert for Nov 8
JFrog Ltd. [FROG] is up 26.96% over the past day.
